Status:
COMPLETED
A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Herpes Zoster
Eligibility:
All Genders
50+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether the refrigerator-stable formulation of an investigational vaccine has a comparable immune response (the body's ability to protect against disease) and...
Detailed Description
The duration of treatment is 4 weeks.
Eligibility Criteria
Inclusion
- Individuals who are at least 50 years of age or older with a history of varicella (chicken pox)
Exclusion
- Prior history of herpes zoster (shingles)
- Prior receipt of varicella or zoster vaccine
- Immunosuppressed
Key Trial Info
Start Date :
August 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2005
Estimated Enrollment :
368 Patients enrolled
Trial Details
Trial ID
NCT00130793
Start Date
August 1 2005
End Date
November 1 2005
Last Update
January 26 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.